RT Journal Article
SR Electronic
T1 Skin staining following intravenous iron infusion
JF BMJ Case Reports
JO BMJ Case Reports
FD BMJ Publishing Group Ltd
SP e229113
DO 10.1136/bcr-2018-229113
VO 12
IS 6
A1 Clare Margaret Crowley
A1 Gabriela McMahon
A1 Joanna Desmond
A1 Mendinaro Imcha
YR 2019
UL http://casereports.bmj.com/content/12/6/e229113.abstract
AB This report describes the case of a 36-year-old woman, gravida 3, para 2, at 11 weeks' gestation, who received a ferric carboxymaltose infusion for iron deficiency anaemia after medical management of a miscarriage. The following morning, light brown skin staining was noted at the infusion site, and the staining was present 2 months later at follow-up. Skin staining following intravenous iron infusion is a rare but important side effect. The skin staining is potentially permanent but may fade in time. Such an adverse effect may have cosmetic consequences for the patient.